AWARD
70 -- Award Notice/Posting of LSJ
- Notice Date
- 9/30/2013
- Notice Type
- Award Notice
- NAICS
- 511210
— Software Publishers
- Contracting Office
- Department of the Navy, Bureau of Medicine and Surgery, NMLC, 693 Neiman Street, FT Detrick, Maryland, 21702-9203, United States
- ZIP Code
- 21702-9203
- Solicitation Number
- N6890113RCW0030
- Archive Date
- 10/1/2013
- Point of Contact
- Courtney A. Piar, Phone: 301-619-7467
- E-Mail Address
-
courtney.piar@med.navy.mil
(courtney.piar@med.navy.mil)
- Small Business Set-Aside
- N/A
- Award Number
- N6264513F0049
- Award Date
- 9/16/2013
- Awardee
- Dialog Medical , 30 Perimeter Park Suite 200, Atlanta , Georgia 30341, United States
- Award Amount
- 6,036404.00
- Description
- LIMITED SOURCE JUSTIFICATION 1. IDENTIFICATION OF THE AGENCY AND THE CONTRACTING ACTIVITY: This is a Limited Source Justification. The Naval Medical Logistics Command (NMLC), acting on behalf of the Naval Medicine Information Systems Support Activity (NAVMISSA) at San Antonio, TX, intends to award a delivery order against Federal Supply Schedule contract, Contract No. GS-35F-0161U. 2. NATURE/DESCRIPTION OF CONTRACT ACTION: This is a limited source action for iMedConsent TM web-based medical software to improve quality of care and provider satisfaction in conjunction with Navy Medicine clinical practice at all 28 Navy Military Treatment Facilities (MTFs)and 1 Army Medical Center. The software is manufactured by Dialog Medical®, 3075 Breckinridge Blvd., Suite 474, Duluth, GA 30096. The Government intends on awarding a Firm Fixed Price delivery order. 3. DESCRIPTION OF REQUIRED SUPPLIES/SERVICES: The proposed acquisition is for iMedConsent TM web-based medical software manufactured by Dialog Medical®, and their Clinical Content annual license. Interface/integration services to integrate iMedConsent with the Department of Defense (DoD) Medical systems Composite Health Care System (CHCS), Essentris and AHLTA. Implementation and training support, both on-site and off-site and basic USB signature pads. Informed consent is a process that includes identifying the appropriate decision maker, providing standardized information about a proposed treatment or procedure and its alternatives in a way that is clear to the patient, using a combination of necessary clinical terminology with appropriate clarifications in patient-friendly verbiage, supporting voluntary decision making, and documenting the process. Informed consent for medical treatments and procedures is not optional, but is a legal requirement and essential to high quality patient care. For treatments and procedures that pose special risks, informed consent includes the additional step of completing a consent form with signatures. The informed consent process must provide for an enterprise implementation, an informed consent template that meets the Navy's current OF522 formats and informed consent policy, as applicable, a comprehensive content library; integration with other healthcare IT applications including the Electronic Medical Record (EMR) and document management systems (AHLTA); electronic signature capture for a paperless process; automatic creation of progress note to document encounter; advance directives module; "distributed" program access at the facility; on-site implementation and training; document building; off-site maintenance support; and English and Spanish language documents. The contract will have a base plus four (4) option years. 4. IDENTIFICATION OF THE JUSTIFICATION RATIONALE AND/OR DEMONSTRATION OF CONTRACTOR'S UNIQUE QUALIFICATIONS: The statutory authority which permits restricting consideration of schedule contractors to fewer than that required in FAR 8.405-1 (SUPPLIES) is 41 U.S.C. 251, as implemented by FAR 8.405-(6)(b)(1)- Only one source is capable of responding. The proposed acquisition is for iMedConsent TM web-based medical software manufactured by Dialog Medical®, and their Clinical Content annual license. Interface/integration services to integrate iMedConsent with the Department of Defense (DoD) Medical systems Composite Health Care System (CHCS), Essentris and AHLTA. Implementation and training support, both on-site and off-site and basic USB signature pads. The Navy Medical Department is currently leasing and using the iMedConsent software in our MTFs in an automated paper based scenario. Dialog Medical is the sole reseller and proprietary manufacturer of iMedConsent. No other vendor can provide this product except the manufacturer Dialog Medical. iMedConsent is required by ethical standards, Joint Commission standards, and Federal law. Informed consent for treatments and procedures is a legal requirement and essential to high quality patient care. iMedConsent meets all legal and Joint Commission requirements. iMedConsent enhances the education, discussion and documentation of informed consent and other patient communication processes, including the capability to print customized documents. iMedConsent is the only product capable of providing a standardized, GLOBAL informed consent, a Spanish language version and has applicability to interface with CHCS, Essentris and AHLTA. iMedConsent is the only web-based process found that provides both a comprehensive content library and an electronic signature capture for a paperless system. iMedConsent features an advance directive module, includes automatic creation of a progress note to document the patient encounter, provides "distributed" program access at the facility, and includes on-site implementation and training. All researched products identified in paragraph 6 provide features/functionality that are not compatible with or are not utilized by informed consent. The other products are only focused on research, and/or are very focused on only limited clinical areas. While they are all interactive in scope, they lack the necessary comprehensive clinical content library, the Spanish language version, and have limited to no applicability to interface with CHCS, Essentris and AHLTA. iMedConsent TM is a proven application and is the standardized informed consent process currently in use at other DOD Agencies such as The Veteran Affairs (VA) medical treatment facilities, US Army Medical facilities and by more than 15,000 physicians in over 175 hospitals and physician practices nationwide. The Navy Medicine completed two successful pilot projects of iMedConsent at Navy facilities (Portsmouth and Pensacola) in the summer of 2008. Currently, seventeen (17) Navy Medical facilities are employing iMedConsent in a limited web based capability to work with AHLTA at a cost lower than its competition. Eight (8) additional Navy Medical facilities will begin to use iMedConsent in a limited web based capacity over the next three (3) months. 5. DETERMINATION OF BEST VALUE: In accordance with FAR 8.404(d), the GSA has already determined the prices of equipment and fixed price services of the schedule contracts to be fair and reasonable. Therefore, ordering activities are not required to make a separate determination of fair and reasonable pricing. The Contracting Officer will determine, using the procedures in FAR 8.405, that the order represents the best value and results in the lowest overall cost alternative (considering price, special features, administrative costs, etc.) to meet the Government's needs. The Contracting Officer may also seek additional discounts before placing the order. 6. DESCRIPTION OF MARKET RESEARCH: Market research was conducted by technical experts using the World Wide Web. The general Web search provided software of the interactive type such as My Informed Choice TM by Medical Animatics, LLC. My Informed Choice TM combines cutting-edge medical animation and video into an easy-to-use interactive design currently delivering patient education and electronic informed consent tools to bariatric practices across the nation. Chicago-based Emmi Solutions is helping hospitals design new informed-consent forms with its EmmiPrep®, an interactive program that patients can view on a home computer prior to signing. VisionTree Optimal Care TM (VTOC) is a proven and secure paperless patient management, documentation and communication system. The above researched products are interactive in scope; however they lack the necessary global clinical content library, lack a Spanish language version, and have limited to no applicability to interface with AHLTA resulting in limited informed consent documentation. All of the applications are either research focused or are focused on select clinical areas. 7. ANY OTHER SUPPORTING FACTS: This procurement uses a GSA Schedule and will be solicited and awarded in accordance with FAR Subpart 8.4. A VHA pre-solicitation notice was issued on August 3, 2007 which yielded only one response from Dialog Medical®. VA solicitation VA-200-07-RP-0029 identified "MPC/Dialog Medical has established themselves as a responsible firm and has performed exceptionally well in supporting the Government's requirements. There are no other sources or resellers of the standard maintenance of the COTS license. 8. ACTIONS TAKEN TO REMOVE BARRIERS TO COMPETITION: All future requirements will be handled on a case-by-case basis. As the barriers that preclude the agency from the requirements of section 8.405-1 (SUPPLIES) are due to limited vendors on schedule, no actions can be taken by this agency to remove those barriers. If additional vendors are added to the FSS for this equipment, they will be considered as applicable.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/DON/BUMED/N62645/Awards/N6264513F0049.html)
- Record
- SN03208348-W 20131002/130930235822-6f5f512cc15fd6ce1bd764d68808030b (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |